Immunodiagnostic Systems Holdings Ltd (IDS) is an in-vitro diagnostic solution provider. The company develops, manufactures, and markets immunoassays and automated immunoanalyser technologies. It conducts research in the areas of bone turnover market, animal research, and other research areas. IDS clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. The company offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. It offers application training and advice, customized training, qualified customer care centers and regionalised proximity teams. The company has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Immunodiagnostic Systems Holdings plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides a detailed description of products in development, technical specifications and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Immunodiagnostic Systems Holdings plc Company Overview
- Immunodiagnostic Systems Holdings plc Company Snapshot
- Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview
- Immunodiagnostic Systems Holdings plc - Pipeline Analysis Overview
- Immunodiagnostic Systems Holdings plc - Key Facts
- Immunodiagnostic Systems Holdings plc - Major Products and Services
- Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage
- Immunodiagnostic Systems Holdings plc Pipeline Products Overview
- IDS-i10 - Infectious Disease Assay
- IDS-i10 - Infectious Disease Assay Product Overview
- IDS-i10 - Allergy Assay
- IDS-i10 - Allergy Assay Product Overview
- IDS-i10 - Autoimmunity Assay
- IDS-i10 - Autoimmunity Assay Product Overview
- IDS-iSYS - 17-beta Estradiol Assay
- IDS-iSYS - 17-beta Estradiol Assay Product Overview
- IDS-iSYS - Androstenedione Assay
- IDS-iSYS - Androstenedione Assay Product Overview
- IDS-iSYS - DHEA-S
- IDS-iSYS - DHEA-S Product Overview
- IDS-iSYS Bioactive PTH (1-84) Kit
- IDS-iSYS Bioactive PTH (1-84) Kit Product Overview
- Immunodiagnostic Systems Holdings plc - Key Competitors
- Immunodiagnostic Systems Holdings plc - Key Employees
- Immunodiagnostic Systems Holdings plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Immunodiagnostic Systems Holdings plc, Recent Developments
- Nov 25, 2019: Omega diagnostics Group: Update on allergy test menu
- Jun 19, 2019: Immunodiagnostic Systems Holdings: Final results for year ended 31 March 2019
- Apr 18, 2019: Immunodiagnostic Systems Holdings: FY2019 trading update
- Apr 01, 2019: THERADIAG signs a development and distribution agreement with IMMUNODIAGNOSTIC SYSTEMS
- Oct 19, 2018: Immunodiagnostic Systems: H1 Trading Update
- Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018
- Apr 04, 2018: Meet IDS at MEDLAB Asia Pacific 2018 from the 2 nd until the 4 th of April
- Mar 29, 2018: Immunodiagnostic Systems Holdings: Launch of two new automated assays
- Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018
- Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017
- Appendix
- Methodology
List of Tables
- Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview
- Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type
- Immunodiagnostic Systems Holdings plc Pipeline Products by Indication
- Immunodiagnostic Systems Holdings plc, Key Facts
- Immunodiagnostic Systems Holdings plc, Major Products and Services
- Immunodiagnostic Systems Holdings plc Number of Pipeline Products by Development Stage
- Immunodiagnostic Systems Holdings plc Pipeline Products Summary by Development Stage
- IDS-i10 - Infectious Disease Assay - Product Status
- IDS-i10 - Infectious Disease Assay - Product Description
- IDS-i10 - Allergy Assay - Product Status
- IDS-i10 - Allergy Assay - Product Description
- IDS-i10 - Autoimmunity Assay - Product Status
- IDS-i10 - Autoimmunity Assay - Product Description
- IDS-iSYS - 17-beta Estradiol Assay - Product Status
- IDS-iSYS - 17-beta Estradiol Assay - Product Description
- IDS-iSYS - Androstenedione Assay - Product Status
- IDS-iSYS - Androstenedione Assay - Product Description
- IDS-iSYS - DHEA-S - Product Status
- IDS-iSYS - DHEA-S - Product Description
- IDS-iSYS Bioactive PTH (1-84) Kit - Product Status
- IDS-iSYS Bioactive PTH (1-84) Kit - Product Description
- Immunodiagnostic Systems Holdings Ltd, Key Employees
- Immunodiagnostic Systems Holdings Ltd, Subsidiaries
List of Figures
- Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type
- Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Source BioScience Ltd
- Smith & Nephew Plc
- EMIS Group Plc
- Almac Diagnostic Services Ltd
- Access Diagnostic Tests UK Ltd
